Effect of a very late antigen‐4 receptor antagonist on allergen‐induced airway responses and inflammation in asthma

@article{Diamant2005EffectOA,
  title={Effect of a very late antigen‐4 receptor antagonist on allergen‐induced airway responses and inflammation in asthma},
  author={Z. Diamant and J. Kuperus and R. Baan and K. Nietzmann and S. Millet and P. Mendes and B. Miller and D. Amin and S. Rohatagi and P. Sterk and H. Hoogsteden and J. Prins},
  journal={Clinical \& Experimental Allergy},
  year={2005},
  volume={35}
}
Background Very late antigen‐4 (VLA4) plays a key role in the recruitment of eosinophils in allergic responses in animal studies. 
View on Wiley
ncbi.nlm.nih.gov
27 Citations
Background Citations
8
Methods Citations
2
Results Citations
1

27 Citations

Citation Type

Citation Type

The effect of a single inhaled dose of a VLA‐4 antagonist on allergen‐induced airway responses and airway inflammation in patients with asthma
Non-invasive sampling methods of inflammatory biomarkers in asthma and allergic rhinitis
Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
Original article: Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis
Strategies for targeting T-cells in allergic diseases and asthma.
Very late antigen-4 integrin antagonists
A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma.
Inhaled allergen bronchoprovocation tests.
Up‐regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid
The rabbit as a model to study asthma and other lung diseases.
...
1
2
3
...

References

SHOWING 1-10 OF 30 REFERENCES
Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4.
Mechanisms regulating eosinophil extravasation in asthma.
  • E. Knol, D. Roos
  • Medicine
  • The European respiratory journal. Supplement
  • 1996
The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents.
A small molecule very late antigen-4 antagonist can inhibit ovalbumin-induced lung inflammation.
The effect of anti-integrin monoclonal antibodies on antigen-induced pulmonary inflammation in allergic rabbits.
Reproducibility of allergen-induced early and late asthmatic responses.
Allergen‐induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation
Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.
Alpha 4 integrin antagonists.
  • D. Jackson
  • Biology, Medicine
  • Current pharmaceutical design
  • 2002
...
1
2
3
...